G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 96 filers reported holding G1 THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $5 | -54.5% | 2,026 | 0.0% | 0.00% | – |
Q4 2022 | $11 | -99.9% | 2,026 | -11.0% | 0.00% | – |
Q1 2022 | $18,000 | -21.7% | 2,277 | 0.0% | 0.00% | – |
Q4 2021 | $23,000 | -25.8% | 2,277 | 0.0% | 0.00% | – |
Q3 2021 | $31,000 | -38.0% | 2,277 | 0.0% | 0.00% | – |
Q2 2021 | $50,000 | -7.4% | 2,277 | 0.0% | 0.00% | – |
Q1 2021 | $54,000 | +31.7% | 2,277 | 0.0% | 0.00% | – |
Q4 2020 | $41,000 | +57.7% | 2,277 | 0.0% | 0.00% | – |
Q3 2020 | $26,000 | -52.7% | 2,277 | 0.0% | 0.00% | – |
Q2 2020 | $55,000 | +120.0% | 2,277 | 0.0% | 0.00% | – |
Q1 2020 | $25,000 | -58.3% | 2,277 | 0.0% | 0.00% | – |
Q4 2019 | $60,000 | -25.0% | 2,277 | -12.8% | 0.00% | – |
Q2 2019 | $80,000 | +86.0% | 2,612 | 0.0% | 0.00% | – |
Q1 2019 | $43,000 | -10.4% | 2,612 | 0.0% | 0.00% | – |
Q4 2018 | $48,000 | -65.0% | 2,612 | 0.0% | 0.00% | – |
Q3 2018 | $137,000 | +21.2% | 2,612 | 0.0% | 0.00% | – |
Q2 2018 | $113,000 | +189.7% | 2,612 | +148.3% | 0.00% | – |
Q1 2018 | $39,000 | +85.7% | 1,052 | 0.0% | 0.00% | – |
Q4 2017 | $21,000 | – | 1,052 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |